慢性阻塞性肺疾病合并肌少症  

Sarcopenia in chronic obstructive pulmonary disease

作　　者：南亚昀 彭琳琳[1] 高叙凡[1] 盛思敏 周宇婷 李雪兵 陈琼[1] NAN Ya-yun;PENG Lin-lin;GAO Xu-fan;SHENG Si-min;ZHOU Yu-ting;LI Xue-bing;CHEN Qiong(Department of Geriatrics,National Clinical Research Center for Geriatric Disorders,Xiangya Hospital,Central South University,Changsha 410008,China)

机构地区：[1]中南大学湘雅医院老年医学科国家老年疾病临床医学研究中心,湖南长沙410008 [2]宁夏回族自治区人民医院宁夏老年医学中心,宁夏银川750001

出　　处：《中国实用内科杂志》2022年第8期626-630,共5页Chinese Journal of Practical Internal Medicine

基　　金：国家重点研发计划项目(2020YFC2008600,2020YFC2008605);宁夏医科大学科学研究基金资助项目(XZ2021021)。

摘　　要：慢性阻塞性肺疾病是呼吸系统最常见的慢性疾病,肌少症是其重要合并症,发生率为4.4%~86.55%;肌少症严重影响慢性阻塞性肺疾病进展和预后。文章就近年来慢性阻塞性肺疾病合并肌少症的研究进展综述,以此提高临床医生对慢性阻塞性肺疾病合并肌少症的认识,期望达到早期识别、早预防、早期诊断、早期干预和个体化管理。Chronic obstructive pulmonary disease(COPD)is one of the most prevalent chronic diseases in the respiratory system,and sarcopenia is one of its most important comorbidities.Patients with chronic obstructive pulmonary disease are more likely to have sarcopenia,with an estimated incidence of 4.4%to 86.55%;sarcopenia is closely related to the prognosis of patients with chronic obstructive pulmonary disease.This article reviews the recent researches of sarcopenia in chronic obstructive pulmonary disease,aiming to improve clinicians’understanding of sarcopenia in chronic obstructive pulmonary disease,and achieve the purpose of the early identification and individualized management of sarcopenia in COPD.

关 键 词：慢性阻塞性肺疾病 肌少症 

分 类 号：R592[医药卫生—老年医学]